<DOC>
	<DOCNO>NCT01780129</DOCNO>
	<brief_summary>HW6 prolong animal 's survival time increase survival rate . HW6 enhance cardiac function , improve microcirculation , increase blood pressure pulse pressure , improve blood perfusion important organ ; HW6 's anti-shock activity come combine multiple target pharmacological effect . Based complete phase II trial conduct China , HW6 effectively treatment shock patient . This phase II clinical study evaluate efficacy safety Polydatin Injectable 100mg/5mL/via ( HW6 ) treatment shock United States . Patients traumatic/hemorrhagic shock septic shock admit emergency room ICU systolic blood pressure &lt; 90mmHg , vasopressor ( ) systolic blood pressure stabilization , regardless type complete , on-going , projected Standard Care surgery recruit participant trial . A total 120 patient traumatic/hemorrhagic shock 120 patient septic shock enrol . For type shock , sixty patient test group control group . Both adult male female age 18-80 year eligible . The primary clinical endpoint time length ( TL ) start HW6 administration onset first treatment success , : systolic blood pressure stabilize ≥90mmHg MAP≥65mmHg 1 hour without use vasopressor . Several secondary endpoint biomarkers measure . Efficacy data compare use group t-test Wilcoxon log-rank test treatment group placebo group . Safety data also report accordingly .</brief_summary>
	<brief_title>Polydatin Injectable ( HW6 ) Shock Treatment</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Shock , Hemorrhagic</mesh_term>
	<mesh_term>Shock , Traumatic</mesh_term>
	<criteria>Adult male female age 1880 year . Patients traumatic/hemorrhagic shock septic shock admit emergency room ICU systolic blood pressure &lt; 90mmHg , vasopressor ( ) systolic blood pressure stabilization , regardless type complete , ongoing , project Standard Care surgery . Patients ( relative ) sign Informed Consent Form voluntarily participate clinical study . Has know allergic constitution history alcohol drug allergy . Complicating acute cardiac failure , acute renal failure , acute liver failure disseminate intravascular coagulation ( DIC ) . Pregnant lactating woman . Complicating moderate severe craniocerebral injury . Has know previous severe chronic disease ( ) liver , kidney , carvascualr system central nervous system .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>